gvtcx

Genomics Unit - National External Quality Assessment Service (NEQAS)

NHS England Published 18 Apr 2023 Contracts Finder

key details

Value£1,500,000
Statuscomplete
Category (CPV) 85100000
Deadline1 Mar 2021
Contract start1 Apr 2021
Contract end31 Mar 2023
Proceduredirect
SME suitableNo
OCIDocds-b5fd17-c6e8d8ae-6b92-4b74-9be1-67a1da7056fe

Award

SupplierValueDateStatus
Lothian Health Board £1,500,000 12 Jul 2021 active

description

Current Arrangements / Context

Building on the 100,000 Genomes Project and existing genetic services, In October 2018 NHS England announced the launch of the NHS Genomic Medicine Service (GMS) which will be mobilised as part of a transition period to take place over 18 months. The long term aims of the Genomic Medicine Service are to:

oProvide consistent and equitable care for England's 55 million population
oOperate to common national standards, specifications and protocols
oDeliver to a single national genomic testing directory - covering use of all technologies from single gene to whole genome sequencing initially for rare disease and cancer
oGive all patients the opportunity to participate in research (for individual benefit and to inform future care)
oBuild a national genomic knowledge base providing real world data

This procurement relates to external quality assurance of the samples and the DNA material taken at NHS Genomic Laboratory Hubs as part of the new Genomic Medicine Service. Such sequencing requires high quality DNA and to ensure these samples are provided by the NHS Genomic Medicine Centres (GMCs), a range of external quality assessment (EQA) schemes are required. An assured lab network of GLHs will provide the required assurance to the wider GMS (including for clinical genetics services and Genomic Medicine Centres established as part of the 100,000 Genomes Project).

The quality assurance measures are concentrated on 5 major areas. NHS England are obligated to provide a quality assurance service to ensure samples collected are of high enough quality to extract a full genome.

The required EQA service is as follows:

EQA for DNA extraction from blood samples
EQA for DNA extraction for formalin fixed paraffin embedded (FFPE) tissue samples
EQA for the measurement of DNA quality
EQA for the assessment of tumour content and cellularity
EQA for the National Genomic Testing Directory

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
18 Apr 2023 Award (award) · 9b166e64-0f97-4c6a-8519-d2df9eec65fb-636918

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.